Coexistence of Two Novel Mutations in CDKN2A and PMS1 Genes in a Single Patient Identifies a New and Severe Cancer Predisposition Syndrome
Oncomedicine · 2017
DOI: 10.7150/oncm.19362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Marco Cassone und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cassone, M., Salehi, L. B., Tedaldi, G., Tebaldi, M., Zampiga, V., Biancolella, M., Testa, B., Calistri, D., Mastrogiorgio, G., Lanciotti, S., D'Apice, M. R., Novelli, G., & Sangiuolo, F. (2017). Coexistence of Two Novel Mutations in CDKN2A and PMS1 Genes in a Single Patient Identifies a New and Severe Cancer Predisposition Syndrome. Oncomedicine. https://doi.org/10.7150/oncm.19362
Vancouver
Cassone M, Salehi LB, Tedaldi G, Tebaldi M, Zampiga V, Biancolella M, et al. Coexistence of Two Novel Mutations in CDKN2A and PMS1 Genes in a Single Patient Identifies a New and Severe Cancer Predisposition Syndrome. Oncomedicine. 2017. doi:10.7150/oncm.19362
BibTeX
@article{Cassone2017,
author = {Cassone, Marco and Salehi, Leila Baghernajad and Tedaldi, Gianluca and Tebaldi, Michela and Zampiga, Valentina and Biancolella, Michela and Testa, Barbara and Calistri, Daniele and Mastrogiorgio, Gerarda and Lanciotti, Silvia and D'Apice, Maria Rosaria and Novelli, Giuseppe and Sangiuolo, Federica},
title = {Coexistence of Two Novel Mutations in CDKN2A and PMS1 Genes in a Single Patient Identifies a New and Severe Cancer Predisposition Syndrome},
journal = {Oncomedicine},
year = {2017},
doi = {10.7150/oncm.19362}
}
EUVIMED